European Cluster Partnerships on Personalised Healthcare
bioXclusters Plus is a European initiative that unites four leading biotechnology and health clusters in Europe: Biocat (Catalonia, Spain); Bio M (Bavaria, Germany); bioPmed (Piemonte, Italy); Lyonbiopole (Auvergne-Rhône-Alpes, France). Together, this alliance represents 3,300 SMEs, mainly in the fields of personalised medicine, oncology , cardiovascular , inflammatory and infectious diseases . It is supported by the European Union’s COSME programme and is part of the European Cluster Collaboration Platform initiative.
bioXclusters Plus has one single overarching aim: to support the competitiveness of SMEs by facilitating internationalization and the creation of a single European entry point for global players in the life sciences and health sector . It shares best practices with its extensive network of members, stimulating synergies and innovation, and offers key advice, information and a contact point for company entry into strategic, international markets. bioXclusters plus has prioritized the following areas in healthcare for development and support: personalised medicine, regenerative therapies , digital health , and nutrition . Within an environment of open innovation and shared knowledge and contacts, the consortium will promote SME development and market expansion in line with global medical needs.
The strategic alliance has had significant international success since its creation in 2012. Visits by biotech experts from Brazil, China and USA and three fact finding missions to these strategic markets with SME partners led to the signing of six Memorandums of Understanding. In total, 11 international agreements between European SMEs and business partners in these strategic markets were signed in phase 1 of the project.
bioXclusters Plus has now extended its scope to include missions and activities to other new strategic markets, such as Australia or Japan, and is open to explore further win-win collaborations overseas building gateways to targeted markets. Moreover, the 4 cluster organizations which form part of the Council of European BioRegions (CEBR) and the European Cluster Collaboration Platform will provide further opportunity for SME collaboration and growth through a cross-sectorial approach.
Lyonbiopole, a French healthcare cluster fostering innovation in Auvergne-Rhône-Alpes, a vibrant territory in the heart of Europe. It is the cluster which coordinates bioXclusters plus. Lyonbiopole is the gateway to healthcare innovation in Auvergne Rhône-Alpes Region. The cluster supports ambitious projects and companies in the health sector (including infectious diseases, cancer, nutrition, metabolic diseases). Its aim is to support innovative technologies, products and services for a more personalised medicine to the patient’s benefit.
Biocat coordinates and promotes the healthcare and life sciences sector in Catalonia. Its mission is to dynamise and support the public and private stakeholders that make up the BioRegion, Catalonia’s bioscience cluster, which encompasses companies, research groups and bodies, hospitals, universities, administrations and knowledge- and innovation-transfer support structures.
BioM Biotech Cluster Development GmbH is the coordinating agency of the Bavarian Biotech Cluster for all fields of biotechnology. In addition, BioM coordinates the Munich Biotech Cluster with a focus on pharmaceutical biotechnology and personalised medicine. On behalf of the Bavarian Ministry of Economic Affairs, it serves as the one-stop-shop for biotechnology companies and start-ups in the region as well as the first point of contact for international business partners.
bioPmed is the cluster for life sciences and human health for the Piedmont Region of Italy. Launched in 2009, bioPmed is now the result of the formal aggregation of about 70 players, ranging from large multinational corporations to hi-tech start-ups and innovative SMEs, and including universities and research foundations. They all work together and share a solid strategic plan to create innovation and development in the field of health.